GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (STU:S1R) » Definitions » Gross-Profit-to-Asset %

Shanghai Pharmaceuticals Holding Co (STU:S1R) Gross-Profit-to-Asset % : 14.92% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shanghai Pharmaceuticals Holding Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was €4,102 Mil. Shanghai Pharmaceuticals Holding Co's average Total Assets over the quarter that ended in Mar. 2024 was €27,499 Mil. Therefore, Shanghai Pharmaceuticals Holding Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 14.92%.


Shanghai Pharmaceuticals Holding Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Gross-Profit-to-Asset % Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.37 18.49 19.13 16.67 14.89

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.10 15.67 12.93 13.86 14.92

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Gross-Profit-to-Asset % falls into.



Shanghai Pharmaceuticals Holding Co Gross-Profit-to-Asset % Calculation

Shanghai Pharmaceuticals Holding Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=4023.404/( (26828.37+27223.161)/ 2 )
=4023.404/27025.7655
=14.89 %

Shanghai Pharmaceuticals Holding Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=4102.356/( (27223.161+27775.269)/ 2 )
=4102.356/27499.215
=14.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Shanghai Pharmaceuticals Holding Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (STU:S1R) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Shanghai Pharmaceuticals Holding Co (STU:S1R) Headlines

No Headlines